Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibson

Showing results (1241-1250 of 1,857) with videos related to

Pageof 186
Sort By:
The Journal of Investigative Dermatology|January 19, 2006
Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphomaHenry K Wong, Adam J Wilson, Heather M Gibson, et al.
The American Journal of Cardiology|April 1, 1993
Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study GroupP H Stone, C M Gibson, R C Pasternak, et al.
Cell Reports|October 11, 2018
Sensitive Periods for Cerebellar-Mediated Autistic-like BehaviorsPeter T Tsai, Stephanie Rudolph, Chong Guo, et al.
BMJ (Clinical Research Ed.)|November 24, 2018
Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysisLorna M Gibson, Laura Paul, Francesca M Chappell, et al.
The Biochemical Journal|September 1, 1994
Purification and properties of a novel cytochrome: flavocytochrome c from Shewanella putrefaciensC J Morris, A C Black, S L Pealing, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activationA M Birchall, J Bishop, D Bradshaw, et al.
Neuroreport|June 25, 1999
Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodiesA B Singleton, A M Gibson, I G McKeith, et al.
Oncogene|September 21, 2002
MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavageAndrea H Bild, Francisco J Mendoza, Erika M Gibson, et al.
Circulation|May 31, 2001
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudyC M Gibson, J A de Lemos, S A Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2009
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancerB Burtness, M Gibson, B Egleston, et al.
Pageof 186

Showing results (1241-1250 of 1,857) with videos related to

Sort By:
Pageof 186
The Journal of Investigative Dermatology|January 19, 2006
Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphomaHenry K Wong, Adam J Wilson, Heather M Gibson, et al.
The American Journal of Cardiology|April 1, 1993
Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study GroupP H Stone, C M Gibson, R C Pasternak, et al.
Cell Reports|October 11, 2018
Sensitive Periods for Cerebellar-Mediated Autistic-like BehaviorsPeter T Tsai, Stephanie Rudolph, Chong Guo, et al.
BMJ (Clinical Research Ed.)|November 24, 2018
Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysisLorna M Gibson, Laura Paul, Francesca M Chappell, et al.
The Biochemical Journal|September 1, 1994
Purification and properties of a novel cytochrome: flavocytochrome c from Shewanella putrefaciensC J Morris, A C Black, S L Pealing, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activationA M Birchall, J Bishop, D Bradshaw, et al.
Neuroreport|June 25, 1999
Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodiesA B Singleton, A M Gibson, I G McKeith, et al.
Oncogene|September 21, 2002
MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavageAndrea H Bild, Francisco J Mendoza, Erika M Gibson, et al.
Circulation|May 31, 2001
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudyC M Gibson, J A de Lemos, S A Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2009
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancerB Burtness, M Gibson, B Egleston, et al.
Pageof 186